The Carbon Tetrabromide market is estimated valuation of USD 1.9 billion in 2025 projected to reach USD 2.8 billion by 2035, reflecting a compound annual growth rate of 3.7%. This growth trajectory ...

A lawsuit against Johnson & Johnson reveals shocking claims about its baby powder causing serious illnesses, including cancer.

Families sue over baby powder cancer claims - Thousands in the UK are suing Johnson & Johnson, alleging that the company's baby powder products concealed cancer risks ...

More than 3,000 U.K. claimants accuse U.S. pharmaceutical giant Johnson & Johnson of knowingly selling asbestos-tainted talcum powder, making them ill.

A bottle of talcum powder is a bathroom staple for families across the UK. It has long been associated with freshness and care – used by adults and on babies alike to prevent rashes and ease chafing.

Johnson & Johnson and its consumer health arm, Kenvue, are being sued in the UK over possible cancer risks from their talcum powder ...

The sale of baby powder containing talc stopped in the UK in 2023. The UK action mirrors extensive litigation in the US, where multiple lawsuits have been filed and claimants have been awarded ...

In October 2025, a jury ordered J&J to pay nearly $1 Billion to the family of a woman with mesothelioma from the company's talc products.

Learn how FTIR spectroscopy simplifies pharmaceutical formulation by providing rapid, accurate molecular analysis.

We are seeing at the larger university hospitals around Philadelphia daily, if not weekly, these patients with these problems,” Dr. Asif Ilyas told The Post.

Beyond the banks, we hear from Johnson & Johnson, which should have the strongest numbers of any pharmaceutical company.